Does diabetes affect the incidence of non-target lesion revascularization? A meta-analysis of data from randomized controlled trials
Abstract Objective This meta-analysis aimed to specifically investigate whether diabetes mellitus increases the risk of non-target lesion revascularization (NTLR) following percutaneous coronary intervention (PCI), and to assess whether glycemic control and follow-up duration influence this risk. Me...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2026-03-01
|
| Edice: | BMC Endocrine Disorders |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12902-026-02217-x |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
